High-quality neoantigens are immunoedited in long-term survivors of pancreatic cancer
High-quality neoantigens are immunoedited in long-term survivors of pancreatic cancer
OncoAlert and ecancer weekly roundup for February 01 - 06, 2021
OncoAlert Colloquium Day 1: GI tumours and MASCC
Targeting a KRAS neoantigen peptide vaccine to DNGR-1 dendritic cells
OncoAlert and ecancer weekly roundup for November 15 - 21, 2020
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients
Updates in geriatric medical oncology from SIOG meeting
Priorities of cancer research in Nepal
OncoAlert and ecancer weekly roundup for August 17-23 2020
OncoAlert and ecancer weekly roundup for August 1-8 2020
CaRE2 Cancer Research Link© : Pancreatic Cancer Disparities featuring Prof Jose Trevino